SITANOW-M 1000

Manufactured By Intra Life

product type Tab

Composition Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg

Package SIZE

( 10x15 )

100% Authentic
Products

Free
Shipping

Products
Return Policy

Information about SITANOW-M 1000

Description:

  • SITANOW-M 1000 combines sitagliptin 50 mg and metformin hydrochloride 1000 mg in a single oral tablet, designed to enhance glycemic control in adults with type 2 diabetes mellitus. This formulation leverages the complementary mechanisms of a DPP-4 inhibitor and a biguanide to address multiple pathophysiological aspects of diabetes.
  • As one of the trusted sitagliptin tablets 50mg manufacturer, we deliver consistent quality and bioavailability.
  • Our extensive network of sitagliptin tablet distributors and sitagliptin tablet dealers ensures reliable access across domestic and international markets.
  • We’re also recognized among established metformin tablets wholesalers, supporting hospitals, pharmacies, and institutional buyers.
  • For those looking for scale and consistency, we’re your dependable metformin tablets wholesale supplier, offering compliant, ready-to-ship stock.

Key Features:

  • Integrates sitagliptin's incretin-enhancing effects with metformin's insulin sensitization to improve overall glycemic control.
  • Demonstrates significant HbA1c reduction and supports postprandial glucose regulation.
  • Associated with weight neutrality or modest weight loss, beneficial for overweight patients.
  • Once-daily dosing simplifies the regimen, potentially improving patient adherence.
  • Suitable for patients requiring intensified therapy beyond monotherapy.

Usage Guidelines:

  • Administer once daily with meals to minimize gastrointestinal side effects.
  • Appropriate for adults with type 2 diabetes inadequately controlled with metformin alone or those initiating combination therapy.
  • Regular monitoring of renal function is recommended to ensure safe metformin use.

Safety Profile:

  • Common side effects may include gastrointestinal discomfort such as nausea or diarrhea.
  • Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment.
  • Caution advised in patients with hepatic dysfunction or those at risk for lactic acidosis.

Uses / Indications: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.